GARCIA PETER S has filed 14 insider transactions across 2 companies since December 2023.
Most recent transaction: a disposition of 5500 shares of DURECT CORP ($DRRX) on September 11, 2025.
Activity breakdown: 2 open-market purchases and 1 sale.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sept. 11, 2025 | DURECT CORP | $DRRX | GARCIA PETER S | Not found | D | Stock Option (right to buy) | 5500 | $0.00 | 0.0000 | 31,163,000 | 100.00% | 0.02% |
| Sept. 11, 2025 | DURECT CORP | $DRRX | GARCIA PETER S | Not found | U | Common Stock | 12500 | $0.00 | 0.0000 | 31,163,000 | 100.00% | 0.04% |
| Sept. 11, 2025 | DURECT CORP | $DRRX | GARCIA PETER S | Not found | D | Stock Option (right to buy) | 5500 | $0.00 | 0.0000 | 31,163,000 | 100.00% | 0.02% |
| Sept. 11, 2025 | DURECT CORP | $DRRX | GARCIA PETER S | Not found | D | Stock Option (right to buy) | 7000 | $0.00 | 0.0000 | 31,163,000 | 100.00% | 0.02% |
| Sept. 9, 2025 | DURECT CORP | $DRRX | GARCIA PETER S | Not found | M | Stock Option (right to buy) | 5500 | $0.00 | 0.0000 | 31,163,000 | 100.00% | 0.02% |
| Sept. 9, 2025 | DURECT CORP | $DRRX | GARCIA PETER S | Not found | M | Common Stock | 5500 | $1.22 | 12,500.0000 | 31,163,000 | 78.57% | 0.02% |
| Sept. 25, 2024 | DURECT CORP | $DRRX | GARCIA PETER S | Not found | A | Stock Option (right to buy) | 5500 | $0.00 | 5,500.0000 | 31,038,000 | 9999.99% | 0.02% |
| Aug. 14, 2024 | ALX ONCOLOGY HOLDINGS INC | $ALXO | GARCIA PETER S | CHIEF FINANCIAL OFFICER | F | Common Stock | 761 | $2.58 | 121,516.0000 | 0 | 0.62% | 0.00% |
| June 28, 2024 | ALX ONCOLOGY HOLDINGS INC | $ALXO | GARCIA PETER S | CHIEF FINANCIAL OFFICER | F | Common Stock | 1789 | $6.03 | 122,277.0000 | 0 | 1.44% | 0.00% |
| June 13, 2024 | ALX ONCOLOGY HOLDINGS INC | $ALXO | GARCIA PETER S | CHIEF FINANCIAL OFFICER | P | Common Stock | 12000 | $8.53 | 122,348.0000 | 0 | 10.87% | 0.00% |
| June 13, 2024 | ALX ONCOLOGY HOLDINGS INC | $ALXO | GARCIA PETER S | CHIEF FINANCIAL OFFICER | P | Common Stock | 12000 | $8.53 | 122,348.0000 | 0 | 10.87% | 0.00% |
| Feb. 14, 2024 | ALX ONCOLOGY HOLDINGS INC | $ALXO | GARCIA PETER S | CHIEF FINANCIAL OFFICER | A | Employee Stock Option (right to buy) | 80000 | $0.00 | 80,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 14, 2024 | ALX ONCOLOGY HOLDINGS INC | $ALXO | GARCIA PETER S | CHIEF FINANCIAL OFFICER | A | Common Stock | 25000 | $0.00 | 110,348.0000 | 0 | 29.29% | 0.00% |
| Dec. 29, 2023 | ALX ONCOLOGY HOLDINGS INC | $ALXO | GARCIA PETER S | Chief Financial Officer | S | Common Stock | 1893 | $15.04 | 85,348.0000 | 0 | 2.17% | 0.00% |